KLN 205 Syngeneic Model

Synonyms: KLN205, KLN-205, KLN lung carcinoma cell line

KLN 205 is a well-known cancer cell line derived from a murine lung carcinoma. It serves as a valuable tool in lung cancer research, facilitating investigations into tumor biology, metastasis, and therapeutic interventions. KLN 205 cells exhibit characteristics resembling human lung carcinoma, making them suitable for studying the disease. They are frequently utilized to explore genetic alterations, signaling pathways, immune responses, and drug sensitivity in lung cancer research. The cell line is extensively employed in preclinical models to evaluate the efficacy of different treatment approaches, including chemotherapy, targeted therapies, and immunotherapies. KLN 205 plays a significant role in enhancing our understanding of lung cancer and developing novel strategies for its diagnosis and treatment.

Model Details

Cancer Type: Lung Cancer
Model Name: KLN 205
Mouse Strain: DBA-2
Treatment Data Available: N/A

KLN 205 Growth Curve

Growth of subcutaneous KLN 205 in DBA/2 mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content